Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

ClinicalTrials.gov ID: NCT03968159

Public ClinicalTrials.gov record NCT03968159. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 11:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (ACP-103-054/059)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy and safety of adjunctive pimavanserin compared to placebo in subjects with major depressive disorder who have an inadequate response to antidepressant therapy

Study identification

NCT ID
NCT03968159
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
298 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 25, 2019 (Actual)
Primary completion
Apr 30, 2020 (Actual)
Completion
May 29, 2020 (Actual)
Last update posted
Nov 17, 2021

2019 – 2020

United States locations

U.S. sites
41
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
University of Alabama at Birmingham (UAB) Birmingham Alabama 35233 —
CNS Network Garden Grove California 92845 —
Behavioral Research Specialists Glendale California 91206 —
Sun Valley Research Center Imperial California 92251 —
Irvine Clinical Research Irvine California 92614 —
Synergy San Diego Lemon Grove California 91945 —
Pacific Research Partners, LLC Oakland California 94607 —
NRC Research Institute Orange California 92868 —
MCB Clinical Research Centers, LLC Colorado Springs Colorado 80910 —
Mountain View Clinical Research, Inc. Denver Colorado 80209 —
CT Clinical Research Cromwell Connecticut 06416 —
Clinical Neuroscience Solutions ( CNS Healthcare)-Jacksonville Jacksonville Florida 32256 —
Meridien Research Maitland Florida 32751 —
Florida Research Center, Inc. Miami Florida 33174 —
CNS Health Care (Orlando) Orlando Florida 32801 —
Emory University School of Medicine Atlanta Georgia 30322 —
Synexus Clinical Research Atlanta Georgia 30328 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Capstone Clinical Research Libertyville Illinois 60048 —
Collective Medical Research, LLC Prairie Village Kansas 66208 —
Clinical Trials of America (Monroe, LA) Monroe Louisiana 71201 —
Adams Clinical Watertown Massachusetts 02472 —
St. Charles Psychiatric Associates-Midwest Research Group Saint Charles Missouri 63304 —
Integrative Clinical Trials Brooklyn New York 11229 —
Social Psychiatry Research Institute (SPRI) Brooklyn New York 11235 —
Mount Sinai Hospital New York New York 10029 —
The Medical Research Network, LLC New York New York 10128 —
Finger Lake Clinical Research Rochester New York 14618 —
Clinical Trial of America, LLC Hickory North Carolina 28601 —
Charak Clinical Research Center Garfield Heights Ohio 44125 —
Summit Research Network (Oregon) Inc. Portland Oregon 97210 —
University Of Pennsylvania Philadelphia Pennsylvania 19104 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 26464 —
Psychiatric Consultants, PC Franklin Tennessee 37067 —
Clinical Neuroscience Solutions CNS Healthcare Memphis Tennessee 38119 —
Research Strategies of Memphis, LLC Memphis Tennessee 38119 —
Future Search Trials of Dallas Dallas Texas 75231 —
Baylor College of Medicine Houston Texas 77030 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Grayline Research Center Wichita Falls Texas 76309 —
IPC Research Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03968159, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2021 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03968159 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →